UY28401A1 - Metabolito - Google Patents
MetabolitoInfo
- Publication number
- UY28401A1 UY28401A1 UY28401A UY28401A UY28401A1 UY 28401 A1 UY28401 A1 UY 28401A1 UY 28401 A UY28401 A UY 28401A UY 28401 A UY28401 A UY 28401A UY 28401 A1 UY28401 A1 UY 28401A1
- Authority
- UY
- Uruguay
- Prior art keywords
- disorders
- pharmaceutically acceptable
- bipolar
- formula
- effective amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un método para tratar ansiedad, agitación, hostilidad, pánico, trastornos alimenticios, síntomas afectivos, síntomas relacionados con el humor, síntomas psicóticos negativos y positivos comúnmente asociados a esquizofrenia, demencia, ansiedad, depresión, trastornos del humor, trastornos bipolares, manía bipolar, depresión bipolar, trastornos cognitivos y trastornos neurodegenerativos que comprende administrar una cantidad eficaz de Fórmula I o su sal farmacéuticamente aceptable. En otro aspecto, la invención proporciona una composición farmacéutica que comprende una cantidad eficaz de Fórmula I o su sal farmacéuticamente aceptable y al menos un portador o diluyente farmacéuticacmente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48444203P | 2003-07-02 | 2003-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28401A1 true UY28401A1 (es) | 2005-01-31 |
Family
ID=33563990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28401A UY28401A1 (es) | 2003-07-02 | 2004-07-02 | Metabolito |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050026899A1 (es) |
| AR (1) | AR045005A1 (es) |
| TW (1) | TW200507854A (es) |
| UY (1) | UY28401A1 (es) |
| WO (1) | WO2005002587A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8715699B2 (en) | 2009-12-31 | 2014-05-06 | Kempharm, Inc. | Amino acid conjugates of quetiapine, process for making and using the same |
| LT2544536T (lt) | 2010-03-11 | 2019-02-25 | Kempharm, Inc. | Kvetiapino riebalų rūgšties konjugatai, jų gamybos būdas ir panaudojimas |
-
2004
- 2004-06-28 WO PCT/GB2004/002789 patent/WO2005002587A1/en active Application Filing
- 2004-07-01 US US10/882,643 patent/US20050026899A1/en not_active Abandoned
- 2004-07-02 AR ARP040102346A patent/AR045005A1/es not_active Application Discontinuation
- 2004-07-02 UY UY28401A patent/UY28401A1/es not_active Application Discontinuation
- 2004-07-02 TW TW093120090A patent/TW200507854A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200507854A (en) | 2005-03-01 |
| AR045005A1 (es) | 2005-10-12 |
| US20050026899A1 (en) | 2005-02-03 |
| WO2005002587A1 (en) | 2005-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28400A1 (es) | Metabolito | |
| GT200100183A (es) | Derivados de quinolina y quinazolina. | |
| PA8587101A1 (es) | Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos | |
| UY29924A1 (es) | Medicamentos en base a 11-(4-(2-(2-hidroxietoxi)etil)-1-piperazinil)dibenzo-(b,f)(1,4)tiazepina y sus sales farmacéuticamente aceptables | |
| BRPI0412909A (pt) | uso de rnai inibindo atividade de parp para a fabricação de um medicamento para o tratamento de cáncer | |
| AR032086A1 (es) | Combinaciones de farmacos | |
| ECSP067123A (es) | Antagonistas de nk1 | |
| ECSP055719A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
| BRPI0507609A (pt) | combinações terapêuticas de anti-psicóticos atìpicos com antagonistas de fator de liberação de corticotropina | |
| UY27300A1 (es) | Nuevos derivados de quinolina | |
| BRPI0414082A (pt) | formas de dosagem de liberação sustentada de ziprasidona | |
| DOP2006000141A (es) | Derivados de oxindol | |
| BR0314393A (pt) | Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia | |
| BR0314299A (pt) | Derivados de pirrolidona como inibidores de mao-b | |
| BR0207883A (pt) | Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv | |
| AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
| MY152919A (en) | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | |
| BRPI0518785A2 (pt) | composto de anel de 7 membros e mÉtodo de produÇço e aplicaÇço farmacÊutica do mesmo | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| BR0306855A (pt) | Método para o tratamento de distúrbios cognitivos | |
| GT200400068A (es) | Derivados de 3-azabiciclo[3.2.1]octano | |
| UY28401A1 (es) | Metabolito | |
| TW200507846A (en) | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders | |
| ATE345135T1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
| PA8518301A1 (es) | S-metil-dihidro-ziprasidona para el tratamiento de trastornos psiquiatricos y oculares |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150602 |